Genetic and epigenetic basis of clonal advantage during the evolution of acute myeloid leukaemia

Genetic and epigenetic basis of clonal advantage during the evolution of acute myeloid leukaemia

<p>Acute myeloid leukaemia (AML) is an aggressive malignant disorder of immature myeloid cells in the bone marrow. The outcome of older AML patients who are unfit for intensive chemotherapy remains dismal. Relapse, which is the main cause of mortality, occurs due to Darwinian clonal selection...

Bibliografski detalji
Glavni autor:	Turkalj, S
Daljnji autori:	Vyas, P
Format:	Disertacija
Jezik:	English
Izdano:	2024

Slični predmeti

Clonal structures of leukaemia stem cell populations in myeloid blast phase chronic myeloid leukaemia
od: Karamitros, D, i dr.
Izdano: (2016)

The molecular and cellular basis for oncogene collaboration in acute myeloid leukaemia
od: Di Genua, C
Izdano: (2018)

Clonal haematopoiesis and risk of acute myeloid leukemia
od: Young, A, i dr.
Izdano: (2019)

Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
od: Eden, O, i dr.
Izdano: (1998)

Harnessing the graft-versus-leukaemia effect in acute myeloid leukaemia
od: Sweeney, C
Izdano: (2021)

Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.
od: Jan, M, i dr.
Izdano: (2012)

An overview of targeted therapies in acute myeloid leukemia
od: Turkalj, S, i dr.
Izdano: (2023)

Amplification of mitochondrial DNA in acute myeloid leukaemia.
od: Boultwood, J, i dr.
Izdano: (1996)

Immunological weapons against acute myeloid leukaemia.
od: Galea-Lauri, J
Izdano: (2002)

C/EBPalpha mutations in acute myeloid leukaemias.
od: Nerlov, C
Izdano: (2004)

EVI1 expression in acute myeloid leukaemia.
od: Langabeer, SE, i dr.
Izdano: (2001)

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
od: Guinn, B, i dr.
Izdano: (2005)

Less utilized prognostic markers in acute myeloid leukaemia
od: Abdullah, Maha
Izdano: (2016)

Improved outcome of acute myeloid leukaemia in Down's syndrome.
od: Craze, J, i dr.
Izdano: (1999)

Prediction of acute myeloid leukaemia risk in healthy individuals
od: Abelson, S, i dr.
Izdano: (2018)

Randomised studies in acute myeloid leukaemia: the double truth
od: Richards, S
Izdano: (2000)

Gene Expression Profile And Modulation Of Genetic Pathways In Acute Myeloid Leukaemia T(8;21)
od: Bashanfer, Salem Ali Alsalem
Izdano: (2013)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
od: Boultwood, J, i dr.
Izdano: (2004)

Rapid parallel acquisition of somatic mutations after NPM1 in acute myeloid leukaemia evolution
od: Grove, C, i dr.
Izdano: (2016)

Proteomic profile of acute myeloid leukaemia: a review update
od: Almaiman, Amer Abdulrahman, i dr.
Izdano: (2016)

Identification of differentially expressed proteins as biomarkers of acute myeloid leukaemia
od: Barantalab, Fatemeh
Izdano: (2014)

Recent advances in diagnosis of acute myeloid leukaemia : a review.
od: Ambayya, Angeli, i dr.
Izdano: (2013)

Selection of reference genes for quantitative studies in acute myeloid leukaemia
od: Lee, Cindee, i dr.
Izdano: (2019)

Transformation of myelodysplastic syndrome (MDS) to acute myeloid leukaemia (AML)
od: Goh, Chermaine Yu Zhen
Izdano: (2021)

Acute myeloid leukaemia in childhood: the costs and benefits of intensive treatment.
od: Phillips, M, i dr.
Izdano: (1991)

Chemotherapy of acute myeloid leukaemia in adults: Medical Research Council.
od: Cuckle, H, i dr.
Izdano: (1979)

Clonal heterogeneity of acute Myeloid Leukemia treated with the IDH2 inhibitor Enasidenib
od: Vyas, P, i dr.
Izdano: (2018)

ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia
od: Mohd Amin, A, i dr.
Izdano: (2023)

Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia
od: Cressman, S, i dr.
Izdano: (2016)

Clinical relevance of failed and missing cytogenetic analysis in acute myeloid leukaemia
od: Chilton, L, i dr.
Izdano: (2017)

Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
od: Lander, Eric Steven
Izdano: (2017)

Characterising early human lympho-myeloid haematopoietic progenitors and their relationship with acute myeloid leukaemia stem cells
od: Aboukhalil, Z
Izdano: (2018)

Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia
od: Zee, BM, i dr.
Izdano: (2021)

5 ' Azacitidine in Combination with Valproic Acid Induces Complete Remissions in Patients with Advanced Acute Myeloid Leukaemia but Does Not Eradicate Clonal Leukaemic Stem/Progenitor Cells.
od: Craddock, C, i dr.
Izdano: (2008)

The genetic and epigenetic basis of type 2 diabetes and obesity.
od: Drong, A, i dr.
Izdano: (2012)

The genetic and epigenetic basis of type 2 diabetes and obesity
od: Drong, A, i dr.
Izdano: (2012)

Epigenetic regulation of the myeloid cell lineage
od: Pliuskys, L
Izdano: (2014)

Cell viability of acute myeloid leukaemia blasts in culture correlates with treatment outcome
od: Abdullah, Maha, i dr.
Izdano: (2008)

Plasma and cell lysate proteins associated with treatment outcome in acute myeloid leukaemia
od: Barantalab, Fatemeh, i dr.
Izdano: (2020)

Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia.
od: Dixon-McIver, A, i dr.
Izdano: (2008)